Aditxt, Inc. (NASDAQ:ADTX) Short Interest Down 45.2% in December

Aditxt, Inc. (NASDAQ:ADTX) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totalling 99,100 shares, a decline of 45.2% from the November 30th total of 180,800 shares. Based on an average trading volume of 3,270,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.7% of the company’s stock are sold short.

Aditxt Price Performance

Shares of ADTX opened at $0.19 on Friday. The firm has a 50-day moving average of $0.41 and a 200-day moving average of $24.44. Aditxt has a one year low of $0.18 and a one year high of $338.80.

Insider Activity at Aditxt

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of the business’s stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of $1.17, for a total transaction of $29,874.78. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.72% of the stock is owned by company insiders.

About Aditxt

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.